Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
963 daily bars · split adjusted
Current price $69.76
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 12, 26 |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 14, 26 | Grogan William K | officer: Chief Financial Officer | A-Award | 12,840 | — |
Daily · Wilder smoothing
| BTIG |
| maintain |
| Buy |
| Buy |
| Oct 5, 26 | Citigroup | maintain | Neutral | Neutral |
| Oct 5, 26 | Needham | maintain | Buy | Buy |
| Sep 17, 26 | BTIG | maintain | Buy | Buy |
| Aug 19, 26 | BTIG | maintain | Buy | Buy |
| Jul 31, 26 | UBS | maintain | Neutral | Neutral |
| Jul 30, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Jul 30, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Jul 30, 26 | Citigroup | maintain | Neutral | Neutral |
| Sep 14, 26 |
| Grogan William K |
| officer: Chief Financial Officer |
| A-Award |
| 62,256 |
| — |
| Sep 14, 26 | Grogan William K | officer: Chief Financial Officer | A-Award | 31,877 @ $64.25 | $2.05M |
| Sep 14, 26 | Grogan William K | officer | 0 | — |
| Sep 3, 26 | Rackliffe Philip | officer: CEO, AIS | F-InKind | 798 @ $70.56 | $56.31K |
| Sep 3, 26 | O'Neill Kevin Michael | officer: CEO, PDx | F-InKind | 718 @ $70.56 | $50.66K |
| Sep 3, 26 | Newcomb George A. | officer: Chief Accounting Officer | F-InKind | 112 @ $70.56 | $7.90K |
| Sep 3, 26 | Kass-Hout Taha | officer: Chief Technology Officer | F-InKind | 1,502 @ $70.56 | $106.0K |
Classic floor pivots from 2026-10-19
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 61.63 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 83.43 | Oscillator | Sell |
| Williams %R (14) | -19.50 | Oscillator | Sell |
| MACD (12, 26, 9) | 0.59 (Hist 0.68) | Oscillator | Strong Buy |
| Average Directional Index (14) | 22.55 (+DI 30.9 / -DI 15.3) | Trend | Buy |
| EMA 20 | 67.29 | MA | Strong Buy |
| SMA 20 | 66.60 | MA | Strong Buy |
| EMA 50 | 67.28 | MA | Strong Buy |
| SMA 50 | 68.55 | MA | Buy |
| SMA 200 | 70.41 | MA | Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | GEHC | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 20.0x | 17.5x · sector 20.7x | In line |
| Forward P/E (FY26E) | 14.2x | EPS est. 4.92 | Discount |
| Price / Book | 2.9x | 3.4x | Discount |
| Price / Sales | 1.6x | 1.7x | In line |
| EV / EBITDA | 12.9x | 10.7x | Elevated |
| Return on equity | 15.2% | — | Healthy |
| Gross margin | 42.9% | 40.4% | In line |
| Debt / Equity | 0.92 | 0.88 | Moderate |
| Piotroski / Altman Z | 5/9 | Z 1.72 | Distress |
Discounted cash flow model
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
GE HealthCare expands its theranostics imaging push with five global collaborations to evaluate StarGuide GX, targeting advances in precision oncology and nuclear medicine.
GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to
CHICAGO & VIENNA--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse in France; Peking University First Hospital in China; and.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | 1.04 | 1.13 | Beat 8.7% | $5.29B |
| Apr 29, 2026 | 1.04 | 0.99 | Miss -4.8% | $5.13B |
| Feb 4, 2026 | 1.40 | 1.44 | Beat 2.9% | $5.70B |
| Oct 29, 2025 | 1.05 | 1.07 | Beat 1.9% | $5.14B |
| Jul 30, 2025 | 0.92 | 1.06 | Beat 15.5% | $5.01B |
| Apr 30, 2025 | 0.91 | 1.01 | Beat 10.5% | $4.78B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 8-K | Sep 22, 2026 | 2026-09-22 16:07:33 | View |
| 4 | Sep 16, 2026 | 2026-09-16 18:01:59 | View |
| 3 | Sep 16, 2026 | 2026-09-16 18:00:35 | View |
| 4 | Sep 4, 2026 | 2026-09-04 16:46:22 | View |
| 4 | Sep 4, 2026 | 2026-09-04 16:45:05 | View |
| 4 | Sep 4, 2026 | 2026-09-04 16:44:08 | View |
| 4 | Sep 4, 2026 | 2026-09-04 16:43:01 | View |
| 4 | Sep 4, 2026 | 2026-09-04 16:42:24 | View |
| 4 | Sep 4, 2026 | 2026-09-04 16:41:37 | View |
| 4 | Sep 4, 2026 | 2026-09-04 16:40:41 | View |
Proxy statement (DEF 14A) disclosures